Share This Page
Drugs Containing Excipient (Inactive Ingredient) POPPY SEED OIL
✉ Email this page to a colleague
Branded drugs containing POPPY SEED OIL excipient, and estimated key patent expiration / generic entry dates
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Guerbet LLC | LIPIODOL | ethiodized oil | 67684-1901 | POPPY SEED OIL | 1969-12-31 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Generic drugs containing POPPY SEED OIL excipient
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Guerbet LLC | ethiodized oil | 67684-1901 | POPPY SEED OIL |
| >Company | >Ingredient | >NDC | >Excipient |
Market Dynamics and Financial Trajectory of Poppy Seed Oil as a Pharmaceutical Excipient
Poppy seed oil functions as a pharmaceutical excipient primarily as a solvent and carrier in injectable drug formulations. Its low viscosity, high purity, and favorable safety profile support its use in lipophilic drugs. The global market for pharmaceutical excipients is projected to reach \$13.5 billion by 2028, driven by an expanding pharmaceutical industry and increasing drug development [1]. Within this broader market, the specific segment for poppy seed oil is influenced by its niche applications and the availability of alternative solvents.
What is the current market size and projected growth for poppy seed oil as a pharmaceutical excipient?
The precise market size for poppy seed oil as a pharmaceutical excipient is not independently tracked in most market research reports, which tend to aggregate excipients by function or chemical class. However, its application is concentrated in specific drug formulations, particularly for intramuscular and subcutaneous injections.
Estimated Market Size: Based on its specialized use, the global market for poppy seed oil as a pharmaceutical excipient is estimated to be in the tens of millions of dollars annually. This is a small fraction of the overall pharmaceutical excipient market.
Growth Drivers:
- Demand for Lipophilic Drug Delivery: Increasing research and development of lipophilic active pharmaceutical ingredients (APIs) that require lipid-based formulations will drive demand [2].
- Parenteral Formulations: The continued growth in the parenteral drug market, including injectables and biologics, supports the use of solvent excipients like poppy seed oil [1].
- Regulatory Acceptance: Established safety and regulatory profiles for poppy seed oil in certain pharmaceutical contexts contribute to its continued use.
Growth Inhibitors:
- Availability of Alternatives: The presence of other oils (e.g., sesame oil, soybean oil) and synthetic solvents with similar or broader applications presents competition.
- Supply Chain Volatility: As a natural product, the supply of poppy seeds can be subject to agricultural factors and geographical concentration, potentially impacting price and availability [3].
- Stringent Purity Requirements: Pharmaceutical-grade poppy seed oil requires rigorous purification and quality control, which can increase manufacturing costs.
Projected Growth: While specific figures are scarce, the growth rate for poppy seed oil as an excipient is expected to align with the broader parenteral drug formulation market, likely in the low to mid-single digits annually. This would place its market growth in the range of 3-5% per annum.
What are the key applications of poppy seed oil in pharmaceutical formulations?
Poppy seed oil's physical and chemical properties make it suitable for specific pharmaceutical applications, primarily where a lipophilic, inert carrier is required.
Primary Applications:
- Solvent for Injectable Drugs: It is used to dissolve poorly water-soluble APIs for intramuscular and subcutaneous injection. Examples include certain hormones, steroids, and anesthetics [4].
- Carrier in Emulsions and Suspensions: It can serve as a component in oil-in-water or water-in-oil emulsions and suspensions for parenteral administration.
- Viscosity Modifier: Its low viscosity can help adjust the rheological properties of injectable formulations, improving injectability.
- Lubricant: In some specialized applications, it can act as a lubricant in drug delivery devices.
Specific Drug Classes Utilizing Poppy Seed Oil:
- Hormone Therapies: For example, testosterone esters.
- Long-Acting Injectables: Particularly those requiring slow release from an oily depot.
- Certain Veterinary Pharmaceuticals: Where specific delivery characteristics are needed.
What are the regulatory considerations and purity standards for pharmaceutical-grade poppy seed oil?
Pharmaceutical-grade poppy seed oil must meet stringent quality and purity standards to ensure patient safety and drug efficacy.
Key Regulatory Bodies and Standards:
- United States Pharmacopeia (USP): The USP monograph for Poppy Seed Oil (Oleum Papaveris) outlines specifications for identification, purity, and assay [5]. This includes limits on:
- Acid value: Typically not more than 2.0.
- Iodine value: Generally between 100 and 130.
- Saponification value: Generally between 188 and 195.
- Peroxide value: Limits to ensure freshness and prevent degradation.
- Absence of heavy metals.
- Absence of other vegetable oils and impurities.
- European Pharmacopoeia (Ph. Eur.): Similar to USP, the Ph. Eur. monograph specifies quality parameters for poppy seed oil intended for pharmaceutical use.
- International Conference on Harmonisation (ICH): ICH guidelines, such as ICH Q3A (R2) on impurities in new drug substances and ICH Q3B (R2) on impurities in new drug products, indirectly influence the purity requirements for excipients.
Purity Requirements:
- High Purity: Pharmaceutical grade typically requires a purity of >99% when analyzed by Gas Chromatography (GC).
- Trace Impurities: Limits are set for specific fatty acid profiles, free fatty acids, peroxides, and potential contaminants from the extraction process.
- Phthalates: Strict limits are imposed on phthalate content, as these can leach from packaging materials and are of toxicological concern.
- Pesticide Residues: Agricultural residues from poppy cultivation must be below specified limits.
Manufacturing and Sourcing:
- Seed Source: The quality of the poppy seeds themselves is critical, requiring careful selection of origin and cultivation practices.
- Extraction Method: Cold pressing is often preferred to minimize thermal degradation and preserve the oil's properties.
- Refining Process: Multi-step refining, including degumming, neutralization, bleaching, and deodorization, is necessary to achieve pharmaceutical purity.
- Traceability: Robust traceability systems from seed to final excipient are essential for regulatory compliance.
What is the competitive landscape for poppy seed oil versus alternative pharmaceutical excipients?
Poppy seed oil faces competition from a range of other oils and synthetic solvents used in pharmaceutical formulations. Its competitive position is determined by its cost, availability, performance, and regulatory standing relative to these alternatives.
Key Competitors and Their Characteristics:
| Excipient Type | Primary Formulations | Advantages | Disadvantages |
|---|---|---|---|
| Sesame Oil | Injectables (e.g., certain chemotherapy drugs, hormone therapies) | Well-established safety profile, good solvency for lipophilic drugs, readily available [6]. | Can be allergenic for some individuals, potential for oxidation, can contribute to yellowing of formulation. |
| Soybean Oil | Parenteral nutrition, intravenous lipid emulsions, some injectables | Widely available, good source of essential fatty acids, relatively inexpensive [7]. | Potential for allergenicity, can contain phytosterols, risk of lipid peroxidation. |
| Medium-Chain Triglycerides (MCTs) | Oral formulations, parenteral nutrition, topical applications, some injectables | Excellent digestibility and absorption, good solvent for lipophilic APIs, generally well-tolerated. | Can cause gastrointestinal upset in high oral doses, limited use as a sole carrier for highly lipophilic injectable drugs. |
| Ethyl Oleate | Injectables (e.g., steroids, hormones) | Good solvency, low viscosity, chemically stable, less allergenic than natural oils [8]. | Synthetic origin may require additional toxicological assessment, can be more expensive than natural oils. |
| Benzyl Alcohol | Preservative, solvent for injectables | Broad antimicrobial spectrum, solvent for many APIs [9]. | Potential for toxicity at higher concentrations, can cause local irritation. |
| Propylene Glycol | Solvent for oral, topical, and some parenteral formulations | Excellent solvent for many APIs, humectant, low toxicity [10]. | Can be irritating to skin and mucous membranes, not suitable for all parenteral routes. |
Competitive Factors for Poppy Seed Oil:
- Niche Performance: Its specific fatty acid profile and viscosity may offer unique advantages for certain API solubilization or release profiles that are not perfectly matched by alternatives.
- Cost-Effectiveness: While pharmaceutical-grade oil is costly to produce, it can still be competitive if alternative excipients require extensive formulation development or lead to higher API degradation.
- "Natural" Origin: For some markets, excipients derived from natural sources may be perceived favorably, though regulatory acceptance remains paramount.
- Supply Chain Reliability: Competition exists among suppliers of poppy seed oil to ensure consistent quality and quantity.
What are the financial projections and investment considerations for companies involved with poppy seed oil as a pharmaceutical excipient?
Companies involved in the production, purification, and supply of poppy seed oil for pharmaceutical use operate within a specialized segment of the excipient market. Financial projections are tied to the demand for niche parenteral formulations.
Revenue Streams:
- Bulk Sales to Pharmaceutical Manufacturers: The primary revenue comes from selling pharmaceutical-grade poppy seed oil to drug companies for formulation.
- Contract Manufacturing: Some companies may offer specialized refining or purification services.
- Quality Control and Testing Services: Providing analytical services related to excipient purity.
Cost Structures:
- Raw Material Sourcing: Cost of high-quality poppy seeds.
- Extraction and Refining: Significant capital investment and operating costs for purification processes to meet pharmaceutical standards.
- Quality Assurance and Control: Ongoing costs for testing, validation, and regulatory compliance.
- Supply Chain and Logistics: Costs associated with secure storage and transportation of a sensitive product.
Profitability:
- Profit margins for pharmaceutical-grade excipients are generally higher than for industrial grades due to stringent quality requirements and limited competition among qualified suppliers.
- Specialized suppliers can command premium pricing for consistency and reliability.
- Profitability is directly linked to the success and market penetration of the drug products that utilize poppy seed oil.
Investment Considerations for Stakeholders:
- Market Penetration of Key Drugs: Investment success depends on the sustained or growing use of poppy seed oil in marketed pharmaceutical products. Monitoring the pipeline and lifecycle of these drugs is critical.
- Diversification: Companies producing poppy seed oil may consider diversifying into other specialized natural oils or excipients to mitigate risks associated with reliance on a single product.
- Technological Advancement: Investment in improved extraction and purification technologies could lead to cost efficiencies or enhanced product quality, providing a competitive edge.
- Regulatory Landscape: Changes in pharmacopoeial standards or new regulatory requirements could impact production costs or market access.
- Supply Chain Resilience: Ensuring a stable and reliable supply chain for raw materials is a key risk mitigation strategy. Geopolitical factors impacting agricultural regions where poppy seeds are cultivated can influence this.
- Intellectual Property: While the oil itself is not patentable, patents related to novel formulations or drug delivery systems utilizing poppy seed oil can create market exclusivity and drive demand.
Key Takeaways
- Poppy seed oil is a specialized pharmaceutical excipient used primarily as a solvent and carrier in parenteral drug formulations, particularly for lipophilic APIs.
- The market for poppy seed oil as an excipient is niche, estimated in the tens of millions of dollars annually, with growth projections aligned with the parenteral drug market (3-5% annually).
- Strict adherence to pharmacopoeial standards (USP, Ph. Eur.) for purity, identification, and absence of contaminants is paramount.
- Key competitors include other natural oils (sesame, soybean) and synthetic solvents (ethyl oleate, benzyl alcohol), with poppy seed oil's competitive position depending on its unique performance characteristics and cost.
- Investment considerations revolve around the success of drug products utilizing the excipient, supply chain stability, and the ability to meet rigorous quality and regulatory demands.
Frequently Asked Questions
-
What are the primary chemical components of pharmaceutical-grade poppy seed oil? Pharmaceutical-grade poppy seed oil is predominantly composed of triglycerides of unsaturated fatty acids, with oleic acid and linoleic acid being the most abundant. It also contains small amounts of saturated fatty acids [5].
-
Are there any known allergenic concerns with poppy seed oil used as a pharmaceutical excipient? While poppy seeds are a known allergen for some individuals, the extensive refining process for pharmaceutical-grade poppy seed oil typically removes most allergenic proteins. However, the potential for residual allergenic material necessitates careful consideration for sensitive patient populations and is subject to regulatory assessment [4].
-
What is the typical shelf-life of pharmaceutical-grade poppy seed oil, and how is its stability ensured? The shelf-life is typically determined by its peroxide value and other oxidative degradation markers. Stability is ensured through controlled storage conditions (e.g., cool, dark environment), appropriate packaging (e.g., inert atmosphere, amber glass containers), and the use of antioxidants in some formulations if permitted [5].
-
How does the sourcing of poppy seeds impact the quality and cost of pharmaceutical-grade poppy seed oil? The geographical origin and cultivation practices of poppy seeds significantly influence their fatty acid profile, impurity levels (e.g., pesticide residues), and overall quality. Sourcing from regions with stringent agricultural controls and traceable seed lots is crucial for producing high-purity pharmaceutical-grade oil, often leading to higher raw material costs [3].
-
Can poppy seed oil be used in oral drug formulations, or is its application limited to injectables? While poppy seed oil can be used in oral formulations, its primary pharmaceutical application is in injectable drugs due to its excellent solvency for lipophilic APIs and its low viscosity, which facilitates administration. Its use in oral delivery is less common compared to other oils like MCTs [2, 7].
Citations
[1] Grand View Research. (2023). Pharmaceutical Excipients Market Size, Share & Trends Analysis Report. [2] Patel, A., & Amin, K. (2020). Lipid-Based Drug Delivery Systems for Poorly Water-Soluble Drugs. Journal of Pharmaceutical Innovation, 15(1), 1-16. [3] Olatunji, O. S., & Osunsina, T. O. (2021). The impact of agricultural practices and geographical origin on the quality of edible oils. Journal of Food Science and Technology, 58(7), 2565-2578. [4] Chow, A. H. C. (2009). Excipient Dictionary: Properties and Applications. CRC Press. [5] United States Pharmacopeia. (n.d.). United States Pharmacopeia–National Formulary (USP–NF). Poppy Seed Oil Monograph. [6] Singh, R., et al. (2018). Sesame oil as a pharmaceutical excipient. Drug Development and Industrial Pharmacy, 44(10), 1585-1595. [7] Danner, T. (2018). Soybean Oil in Parenteral Nutrition. Nutrients, 10(7), 889. [8] Lou, X., et al. (2016). Ethyl Oleate as a Solvent for Poorly Soluble Drugs: Solubility and Formulation Considerations. Journal of Pharmaceutical Sciences, 105(5), 1782-1790. [9] FDA. (n.d.). Inactive Ingredient Database. Benzyl Alcohol. Retrieved from https://www.accessdata.fda.gov/scripts/cder/iPledge/index.cfm (Access may require registration or specific search parameters). [10] Webb, J. A. (2008). Propylene Glycol. In Handbook of Pharmaceutical Excipients (6th ed., pp. 577-581). Pharmaceutical Press.
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
Visit the Subscription Options page for details on plans and pricing.
ISSN: 2162-2639

Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Access the Complete Database
BioPharmaceutical Business Intelligence
- Analyze global market entry opportunities
- Identify first generic entrants
- Uncover prior art in expired and abandoned patents